RAPT Therapeutics
Latest round
- Series C
Last raised
- Jun 2019
Total raised
- $117M
Investors
- 6
About RAPT Therapeutics
RAPT Therapeutics, Inc.Founded in 2015 and headquartered in San Francisco, US, RAPT Therapeutics, Inc. specializes in the development of therapeutics for inflammatory diseases and cancer. The company has not undergone significant pivots in its business strategy since inception. RAPT was co-founded by Lowri Roberts and Nirav Panchmatia, with Brian Wong currently serving as CEO.RAPT Therapeutics specializes in developing innovative therapeutics aimed at treating inflammatory diseases and cancer. Their core product offerings include RPT904, a long-acting anti-IgE antibody specifically designed to address food allergies, and Tivumecirnon (FLX475), a next-generation CCR4 antagonist targeting Th2-driven disorders such as atopic dermatitis and asthma. These therapies function by intelligently targeting key drivers of the immune system, thus transforming treatment paradigms for patients suffering from these conditions. RAPT's products are primarily intended for use in clinical settings, catering to patients with allergic diseases and various forms of cancer.527 mn. The company generates revenue through partnerships with pharmaceutical companies and agreements with healthcare providers that support the advancement of their therapeutic products.RAPT Therapeutics is strategically positioned for growth through the ongoing development of its product pipeline. The company aims to launch new products designed for the treatment of inflammatory diseases and cancer, with specific timelines yet to be announced. Additionally, RAPT plans to expand its market presence beyond the United States and Europe into other international regions as its offerings mature.984 mn, will be utilized to advance their clinical pipeline and support the commercialization of their products.
Who invested in RAPT Therapeutics
6 investors across 4 rounds
See all investors in RAPT Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RAPT Therapeutics
Who invested in RAPT Therapeutics?
RAPT Therapeutics has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RAPT Therapeutics raised?
RAPT Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did RAPT Therapeutics last raise money?
RAPT Therapeutics's most recent round on record is a Series C, in Jun 2019.
What does RAPT Therapeutics do?
RAPT Therapeutics is a biotechnology company.
Where is RAPT Therapeutics headquartered?
RAPT Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like RAPT Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RAPT Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like RAPT Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.